{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "49401-088",
      "generic_name": "belimumab",
      "labeler_name": "GlaxoSmithKline LLC",
      "brand_name": "BENLYSTA",
      "active_ingredients": [
        {
          "name": "BELIMUMAB",
          "strength": "200 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "49401-088-02",
          "description": "1 SYRINGE in 1 CARTON (49401-088-02)  / 1 mL in 1 SYRINGE (49401-088-01)",
          "marketing_start_date": "20170720",
          "sample": false
        },
        {
          "package_ndc": "49401-088-35",
          "description": "4 SYRINGE in 1 CARTON (49401-088-35)  / 1 mL in 1 SYRINGE (49401-088-01)",
          "marketing_start_date": "20170720",
          "sample": false
        },
        {
          "package_ndc": "49401-088-47",
          "description": "4 SYRINGE in 1 CARTON (49401-088-47)  / 1 mL in 1 SYRINGE (49401-088-42)",
          "marketing_start_date": "20170720",
          "sample": false
        },
        {
          "package_ndc": "49401-088-50",
          "description": "1 SYRINGE in 1 CARTON (49401-088-50)  / 1 mL in 1 SYRINGE (49401-088-42)",
          "marketing_start_date": "20170720",
          "sample": false
        },
        {
          "package_ndc": "49401-088-61",
          "description": "1 SYRINGE in 1 CARTON (49401-088-61)  / 1 mL in 1 SYRINGE",
          "marketing_start_date": "20200602",
          "sample": true
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "GlaxoSmithKline LLC"
        ],
        "rxcui": [
          "1656395",
          "1656398",
          "1656400",
          "1656402",
          "1939296",
          "1939299",
          "1939346",
          "1939348"
        ],
        "spl_set_id": [
          "2fa3c528-1777-4628-8a55-a69dae2381a3"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000182156",
          "N0000182637",
          "N0000182636"
        ],
        "pharm_class_pe": [
          "Decreased B Lymphocyte Activation [PE]"
        ],
        "pharm_class_epc": [
          "B Lymphocyte Stimulator-specific Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "B Lymphocyte Stimulator-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "73B0K5S26A"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "SOLUTION",
      "spl_id": "eb71b011-8919-478c-bed7-b94709fcd596",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20170720",
      "product_id": "49401-088_eb71b011-8919-478c-bed7-b94709fcd596",
      "application_number": "BLA761043",
      "brand_name_base": "BENLYSTA",
      "pharm_class": [
        "B Lymphocyte Stimulator-directed Antibody Interactions [MoA]",
        "B Lymphocyte Stimulator-specific Inhibitor [EPC]",
        "Decreased B Lymphocyte Activation [PE]"
      ]
    }
  ]
}